Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
3 hedge funds and large institutions have $156K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
3.26% less ownership
Funds ownership: 4.99% → 1.73% (-3.3%)
40% less funds holding
Funds holding: 5 → 3 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
68% less capital invested
Capital invested by funds: $493K → $156K (-$338K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
+$2.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$261K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$82K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.92K |
| 4 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$897 |
| 5 |
CASC
Coppell Advisory Solutions Corp
Coppell,
Texas
|
-$897 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $109K | -$261K | -27,631 | -69% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $45K | -$82K | -8,672 | -62% |
|
|
CG
3
Cutler Group
San Francisco,
California
| $2K | +$2.84K | +300 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$4.92K | -549 | Closed |
|
|
CAS
5
Coppell Advisory Solutions
Coppell,
Texas
| – | -$897 | -100 | Closed |
|
|
CASC
6
Coppell Advisory Solutions Corp
Coppell,
Texas
| – | -$897 | -100 | Closed |
|
PILL Hedge Fund Activity: Q1 2023 in Review
3 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q1 2023, worth a combined $156K — down 68% from $493K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PILL and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Cutler Group, opening a new position worth an estimated $2.84K. The largest seller was Susquehanna International Group, cutting an estimated $261K.
- 3 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q1 2023, down from 5 in Q4 2022.
- Funds reported $156K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q1 2023, down 68% quarter-over-quarter.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q1 2023 and 3 closed out, a net change of -2 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q1 2023 was Cutler Group, an estimated $2.84K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q1 2023 was Susquehanna International Group, an estimated $261K sold.
Based on aggregated 13F filings for Q1 2023.